Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma
MedicalXpress Breaking News-and-Events | Apr 05, 2023
Serious consequences identified for young survivors of brain cancer
MedicalXpress Breaking News-and-Events | Mar 30, 2023
Helping your cancer patients with their neuropathy
MDlinx | Mar 30, 2023
Gene variants linked to cerebral arachnoid cysts overlap with developmental disorders, autism, and epilepsy
MedicalXpress Breaking News-and-Events | Mar 10, 2023
Study reinforces potential use of Zika virus to combat prostate cancer but points to possible side-effect
MedicalXpress Breaking News-and-Events | Mar 03, 2023
Blood test for brain cancer may be on horizon, research finds
MedicalXpress Breaking News-and-Events | Mar 01, 2023
Scientists reveal how different cancer cells 'team up' to help incurable childhood brain tumor spread
MedicalXpress Breaking News-and-Events | Mar 01, 2023
Using machine learning to predict brain tumor progression
MedicalXpress Breaking News-and-Events | Jan 17, 2023
Federated machine learning enables the largest brain tumor study to-date, without sharing patient data
MedicalXpress Breaking News-and-Events | Dec 06, 2022
Seeking microscopic clues to beating deadly brain tumors
MedicalXpress Breaking News-and-Events | Nov 02, 2022